Today, Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Takes Center Stage

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Stocks Info

The company is listed on the NASDAQ and operates within the Biotechnology industry segment. The current market capitalization of Biocryst Pharmaceuticals Inc. is $1.32B. A total of 3.66 million shares were traded on the day, compared to an average of 3.66M shares.

In the most recent transaction, McKee Amy E sold 8,600 shares of BCRX for 6.32 per share on Jun 24 ’24. After the transaction, the Director now owns 27,831 company shares. In a previous transaction on Jun 17 ’24, SANDERS MACHELLE sold 4,689 shares at 6.00 per share. BCRX shares that Director owns now total 27,742.

Among the insiders who sold shares, HEGGIE THERESA disposed of 6,698 shares on Jun 14 ’24 at a per-share price of $6.11. This resulted in the Director holding 52,852 shares of BCRX after the transaction. In another insider transaction, LEVIN ALAN G bought 7,861 shares at $6.36 per share on May 30 ’24. Company shares held by the Director now total 44,951.

It has been observed that price targets are rarely accurate, but they can exert some influence from time to time, and are often accepted as valuable in the market. In terms of 52-week highs and lows, BCRX has a high of $7.95 and a low of $4.03.

Balance Sheet Annually/Quarterly

An equity investor’s investment can be viewed on a balance sheet by looking at what assets and liabilities the company has. Investors can determine the company’s prospects by calculating its financial ratios based on this information. BCRX’s latest balance sheet shows that the firm has $507.60M in Cash & Short Term Investments as of fiscal 2021. There were $593.24M in debt and $103.72M in liabilities at the time. Its Book Value Per Share was -$2.31, while its Total Shareholder’s Equity was -$106.99M.

Analysts Opinion

There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for BCRX is Buy with a score of 4.50.

Most Popular

Related Posts